Peter Bach (New York Times)
The CEO Who Saved a Life and Lost His Job
Caroline Chen (Bloomberg BusinessWeek) $CMRX
Teixobactin: A New Antibiotic From a New Platform?
Derek Lowe (In the Pipeline)
FDA Approvals 1996 vs. 2014: The Two Most Prolific Years, But Stark Differences
John LaMattina (Forbes)
TG Therapeutics shows how easy it is to be social media compliant
Brad Loncar (Loncar Blog) $TGTX
The Lone Biotech Bear?
David Grainger (Forbes)